Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study

Wan, Tony; Rodger, Marc; Zeng, Wanzhen; Robin, Philippe; Righini, Marc Philip; Kovacs, Michael J; Tan, Melanie; Carrier, Marc; Kahn, Susan R; Wells, Philip S; Anderson, David R; Chagnon, Isabelle; Solymoss, Susan; Crowther, Mark; White, Richard H; Vickars, Linda; Bazarjani, Sadri; Le Gal, Grégoire

doi:10.1016/j.thromres.2017.11.020

Scientific article

English

Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study

ContributorsWan, Tony; Rodger, Marc; Zeng, Wanzhen; Robin, Philippe; Righini, Marc Philip

; Kovacs, Michael J; Tan, Melanie; Carrier, Marc; Kahn, Susan R; Wells, Philip S; Anderson, David R; Chagnon, Isabelle; Solymoss, Susan; Crowther, Mark; White, Richard H; Vickars, Linda; Bazarjani, Sadri; Le Gal, Grégoire

Published inThrombosis Research, vol. 162, p. 104-109

Publication date2018

Abstract

The optimal duration of oral anticoagulant therapy after a first, unprovoked venous thromboembolism is controversial due to tightly balanced risks and benefits of indefinite anticoagulation. Risk stratification tools may assist in decision making.

Keywords

Anticoagulants/pharmacology/therapeutic use
Cohort Studies
Female
Humans
Male
Middle Aged
Prospective Studies
Pulmonary Embolism/etiology/pathology
Recurrence
Risk Factors

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

La maladie thromboembolique veineuse (808)

Citation (ISO format)

WAN, Tony et al. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study. In: Thrombosis Research, 2018, vol. 162, p. 104–109. doi: 10.1016/j.thromres.2017.11.020

Article (Published version)

Identifiers

PID : unige:115315
DOI : 10.1016/j.thromres.2017.11.020
PMID : 29224973

Journal ISSN0049-3848

451views

0downloads

Creation13/11/2018 12:03:00

First validation13/11/2018 12:03:00

Update27/01/2025 15:20:24

Status update27/01/2025 15:20:24

Last indexation27/01/2025 15:31:13

Archive ouverte UNIGE

Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study

The optimal duration of oral anticoagulant therapy after a first, unprovoked venous thromboembolism is controversial due to tightly balanced risks and benefits of indefinite anticoagulation. Risk stratification tools may assist in decision making.

Technical informations